PATENT CLAIM ANALYSIS

Application Number: 16037150
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "007320"]

Abstract:
The present invention concerns a composition comprising at least three peptides derived from  Mycobacterium tuberculosis  antigen Rv2626c, its use in the diagnostic of latently infected  Mycobacterium tuberculosis  (LTBI) subjects, corresponding methods of use and kits.

Claim (Index 7):
A composition according to  claim 1 , comprising three peptides, in which the amino acid sequences of said three peptides consist of distinctive fragments of from 12 to 20 contiguous amino acids.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.14286
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15505292', '13263442', '15104957', '13119938', '10593384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5904067549708839
- 35 USC 102 Novelty (BERT): 0.5742320402370193
- Combined Prediction Score: 0.5887892834974975
- Mean Citation Score: 364.22367
- Max Citation Score: 527.5229
- Similarity Product: 349.1948171425998

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test